RSS Feeds
Search

Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 1..2 of 2 - per page
Order by
Use of Biological Surfactant as Anti-flammatory Agent and Tissue Preservative Solution
Cancer immunotherapy using dendritic cells, and iii) Camel recombinant antibodies for FoxP3, Mucl & CEA. More
Tackling challenges of poor solubility
Enhancing the dissolution performance of small and large molecules in a range of dosage forms More
Displaying 1..2 of 2 - per page
Order by

Related Reports

Market Research Reports provided by reports.innovaro.com
Epidemiology: Sepsis – The incidence of severe sepsis is on the rise due to the dramatic aging populations across the developed world
Mar 2011 - 33 pages - $5,700
Sepsis Therapy Area Pipeline Report
Nov 2010 - 85 pages - $1,495
Sepsis Therapeutics - Pipeline Assessment and Market Forecasts to 2017
Jul 2011 - 84 pages - $2,000
Case Study: Sepsis - Xigris’ disappointing performance creates a market opportunity for improved sepsis therapies
May 2011 - 36 pages - $1,900
R&D Trends: Sepsis - Improvements in clinical trial design and advances in biomarker research hold the key to a tailored approach to sepsis therapy
Apr 2011 - 40 pages - $3,800
Sepsis - Pipeline Review, Q4 2010
Dec 2010 - 63 pages - $500
Sepsis - Pipeline Review, H2 2011
Aug 2011 - 157 pages - $500
Sepsis - Pipeline Review, Q2 2011
Apr 2011 - 104 pages - $500
Stakeholder Opinions: Sepsis - The Critical Care Community Gains Critical Mass
Mar 2008 - 124 pages - $3,800
Terumo to Buy Blood Transfusion Business from Gambro: To become the Largest Player in the Blood Transfusion Market - Deal Analysis From GlobalData
Mar 2011 - 6 pages - $500
More Related Market Research Reports >>>

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2012 Innovaro Europe Ltd Innovaro Corporation All rights reserved. Terms and Conditions | Contact us